FinTech
Argenica Therapeutics: Completes phase one clinical trial dosing of ARG-007
Argenica Therapeutics Completes phase one clinical trial dosing of ARG-007Argenica Therapeutics (AGN) completes the dosing stage of a phase one clinical trial of...
FinTech
Argenica Therapeutics: Receives approval to commence final ARG-007 dosing
Argenica Therapeutics Receives approval to commence final ARG-007 dosingArgenica Therapeutics (AGN) receives approval to progress to the fourth and final cohort dosing of...
FinTech
Argenica Therapeutics: Raises $5.5m for clinical trials
Argenica Therapeutics Raises $5.5m for clinical trialsPharmaceutical company Argenica Therapeutics (AGN) receives binding commitments to raise $5.5 million via a placement
The funds...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
